Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate

International Journal of Cancer

Volumn 65, Issue 5, 1996, Pages 613-619

  Norris, Murray D ^a   De Graaf, David ^b   Haber, Michelle ^a   Kavallaris, Maria ^a   Madafiglio, Janice ^a   Gilbert, Jayne ^a   Kwan, Edward ^a   Stewart, Bernard W ^a   Mechetner, Eugene B ^b,c   Gudkov, Andrei V ^b   Roninson, Igor B ^b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Oncotech Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; GLYCOPROTEIN P; METHOTREXATE; VERAPAMIL; VINBLASTINE; VINCRISTINE;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BIOLOGICAL TRANSPORT; CELL DIVISION; CHICK EMBRYO; DRUG RESISTANCE, MULTIPLE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METHOTREXATE; P-GLYCOPROTEIN; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 13344277328     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960301)65:5<613::AID-IJC10>3.0.CO;2-8     Document Type: Article

References (21)

1. ARKIN, H., OHNUMA, T., KAMEN, B.A., HOLLAND, J.F. and VALLABHAJOSULA, S., Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate. Cancer Res., 49, 6556-6561 (1989).
2. ASSARAF, Y.G., MOLINA, A. and SCHIMKE, R.T., Cross-resistance to the lipid-soluble antifolate, trimetrexate, in human carcinoma cells with the multidrug-resistant phenotype. J. nat. Cancer Inst., 81, 290-294 (1989).
3. BECK, W.T., Cellular pharmacology of Vinca alkaloid resistance and its circumvention. In: G. Weber (ed.), Advances in enzyme regulation, pp. 207-227, vol. 22, Pergamon Press, New York (1984).
4. 2 in children with acute lymphoblastic leukemia. Cancer, 60, 5-13 (1987).
5. CHALDHARY, P.M. and RONINSON, I.B., Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell, 66, 85-94 (1991).
6. CHAUDHARY, P.M. and RONINSON, I.B., Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. nat Cancer Inst., 85, 632-639 (1993).
7. CHEN, C.J., CHIN, J.E., UEDA, K., CLARK, D.P., PASTAN, I., GOTTESMAN, M.M. and RONINSON, I.B., Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell, 47, 381-389 (1986).
8. CHOI, K., FROMMEI., T.O., KAPLAN-STERN, R., PEREZ, C.F., KREIGLER, M., TSURUO, T. and RONINSON, I.B., Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection. Proc. nat. Acad. Sci. (Wash.), 88, 7386-7390 (1991).
9. DE GRAAF, D., SHARMA, R.C., MECHETNER, E.B., SCHIMKE, R.T and RONINSON, I.B., P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake. Proc. nat. Acad Sci. (Wash.) (1995) (In Press).
10. GOTTESMAN, M.M. and PASTAN, I., Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem., 62, 385-427 (1993).
11. HABER, M., REED, C., KAVALLARIS, M., NORRIS, M.D. and STEWART, B.W., Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate. J. nat. Cancer Inst., 81, 1250-1254 (1989).
12. HENDERSON, G.B. Folate binding proteins. Ann. Rev. Nutr., 10, 319-335 (1990).
13. HILL, B.T., DEDHAR, S. and GOLDIE, J.H., Evidence that at "high" extracellular methotrexate concentrations the transport barrier is unlikely to be an important mechanism of drug resistance. Biochem. Pharmacol., 31, 263-266 (1982).
14. KAVALLARIS, M., HABER, M., NORRIS, M.D., MATHERLY, L.H. and STEWART, B.W., Characterization of mechanisms mediating drug resistance in human leukemic cells selected with high concentration methotrexate. Pteridines, 3, 119-121 (1992).
15. KAVALLARIS, M., HABER, M., NORRIS, M.D., PITTMAN, S.M., REED, C. and STEWART, B.W., Phenotypic and cytogenetic analysis of atypical multidrug resistance in human leukaemic cells selected with MTX at high concentration. Cancer Lett., 51, 193-201 (1990).
16. MECHETNER, E.B. and RONINSON, I.B., Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc. nat. Acad. Sci. (Wash.), 89, 5824-5828 (1992).
17. NEYFAKH, A.A., Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp. Cell Res., 174, 168-176 (1988)
18. NOONAN, K., BECK, C., HOLTZMAYER, T., CHIN, J.E., WUNDER, J.S., ANDRULIS, I.L., GAZDAR, A.F , WILLMAN, C.L., GRIFFITH, B., VON HOFF, D.D. and RONINSON, I.B., Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. nat. Acad. Sci. (Wash.), 87, 7160-7164 (1990).
19. NORRIS, M.D., HABER, M., KAVALLARIS, M., BRIAN, M.J., LUTZE, L.H., WHITE, L. and STEWART, B.W., Reduced drug accumulation as the mechanism of extreme clinical resistance to methotrexate in the human T-cell leukaemia xenograft. LALW-2. Cancer, 68, 981-987 (1991).
20. NORRIS, M.D., HABER, M., KING, M. and DAVEY, R.A., Atypical multidrug resistance in CCRF-CEM cells selected for high level methotrexate resistance: reactivity to monoclonal antibody C219 in the absence of P-glycoprotein expression. Biochem. biophys. Res. Comm., 165, 1435-1441 (1989).
21. RONINSON, I.B. (ed.) Molecular and cellular biology of multidrug resistance in tumor cells, Plenum, New York (1991).